| Title | Brg1 controls stemness and metastasis of pancreatic cancer through regulating hypoxia pathway. |
| Publication Type | Journal Article |
| Year of Publication | 2023 |
| Authors | Araki O, Tsuda M, Omatsu M, Namikawa M, Sono M, Fukunaga Y, Masuda T, Yoshikawa T, Nagao M, Ogawa S, Masuo K, Goto N, Muta Y, Hiramatsu Y, Maruno T, Nakanishi Y, Koyasu S, Masui T, Hatano E, Saur D, Fukuda A, Seno H |
| Journal | Oncogene |
| Volume | 42 |
| Issue | 26 |
| Pagination | 2139-2152 |
| Date Published | 2023 Jun |
| ISSN | 1476-5594 |
| Keywords | Animals, Carcinoma, Pancreatic Ductal, Cell Line, Tumor, Cell Proliferation, Humans, Hypoxia, Mice, Pancreatic Neoplasms |
| Abstract | Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease. We previously reported that chromatin remodeler Brg1 is essential for acinar cell-derived PDAC formation in mice. However, the functional role of Brg1 in established PDAC and its metastasis remains unknown. Here, we investigated the importance of Brg1 for established PDAC by using a mouse model with a dual recombinase system. We discovered that Brg1 was a critical player for the cell survival and growth of spontaneously developed PDAC in mice. In addition, Brg1 was essential for metastasis of PDAC cells by inhibiting apoptosis in splenic injection and peritoneal dissemination models. Moreover, cancer stem-like property was compromised in PDAC cells by Brg1 ablation. Mechanistically, the hypoxia pathway was downregulated in Brg1-deleted mouse PDAC and BRG1-low human PDAC. Brg1 was essential for HIF-1α to bind to its target genes to augment the hypoxia pathway, which was important for PDAC cells to maintain their stem-like properties and to metastasize to the liver. Human PDAC cells with high BRG1 expression were more susceptible to BRG1 suppression. In conclusion, Brg1 plays a critical role for cell survival, stem-like property and metastasis of PDAC through the regulation of hypoxia pathway, and thus could be a novel therapeutic target for PDAC. |
| DOI | 10.1038/s41388-023-02716-4 |
| Alternate Journal | Oncogene |
| PubMed ID | 37198398 |
| PubMed Central ID | 2817641 |
| Grant List | 17-24924 / / Princess Takamatsu Cancer Research Fund / 2017bvAg / / Mochida Memorial Foundation for Medical and Pharmaceutical Research / 201910037 / / Mitsubishi Foundation / 201720143 / / Uehara Memorial Foundation / 203190700054 / / Japan Foundation for Applied Enzymology / 203190700083 / / Kanae Foundation for the Promotion of Medical Science (Kanae Foundation) / 200190700011 / / Bristol-Myers Squibb (Bristol-Myers Squibb Company) / 20KI037 / / Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care (Ichiro Kanehara Foundation) / |
